Idexx Laboratories IDXX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $278.45M+12.2% | $248.19M-9.6% | $274.61M-6.6% | $293.99M+21.1% | $242.68M+12.3% | ||
| $37.68M-2.7% | $38.72M+5.7% | $36.63M+2.4% | $35.77M+5.0% | $34.06M+1.1% | ||
| $16.34M+1.4% | $16.11M+11.6% | $14.43M-2.8% | $14.85M+1.6% | $14.62M+2.5% | ||
| $13.89M-55.9% | $31.53M-66.2% | $93.25M+3,662% | $2.48M-37.2% | $3.95M— | ||
| $5M— | —— | $0— | $0— | $0— | ||
| $3.94M+60.9% | $2.45M+51.3% | $1.62M+10.1% | $1.47M-49.1% | $2.89M+61.7% | ||
| $56.81M— | —— | $7.7M-74.0% | $29.65M-34.5% | $45.24M— | ||
| -$2.24M— | —— | —— | $6.24M+389% | -$2.16M-167% | ||
| $11.22M+412% | -$3.6M— | —— | -$3.99M+50.9% | -$8.12M-242% | ||
| $695K-61.0% | $1.78M+1.7% | $1.75M+69.4% | $1.04M+127% | $456K+5.1% | ||
| $266.25M-25.2% | $355.76M-11.6% | $402.34M+117% | $185.74M-21.9% | $237.96M-9.2% | ||
| $31.98M+8.7% | $29.43M-5.4% | $31.11M-8.8% | $34.1M+13.6% | $30.03M+2.6% | ||
| $1.8M+800% | $200K— | —— | —— | $0-100% | ||
| $799K— | —— | —— | —— | $0-100% | ||
| -$33.54M-19.2% | -$28.13M+37.3% | -$44.87M-33.4% | -$33.63M-13.6% | -$29.61M+25.7% | ||
| $351.04M+47.6% | $237.77M-1.0% | $240.2M-29.0% | $338.11M-15.7% | $400.89M+63.0% | ||
| $18.16M+1.6% | $17.87M-64.9% | $50.97M+194% | $17.33M+141% | $7.19M-45.7% | ||
| $10.56M+17,492% | $60K-29.4% | $85K-91.2% | $970K-84.2% | $6.12M+13,509% | ||
| -$211.43M+40.6% | -$355.7M-13.5% | -$313.31M-89.2% | -$165.63M+49.9% | -$330.32M-41.9% | ||
| -$816K— | —— | —— | $14.14M+708% | -$2.33M+76.2% | ||
| $20.46M+173% | -$28.1M— | —— | —— | -$124.3M-510% | ||
| $5M— | —— | $0— | $0— | $0— | ||
| $3.94M+60.9% | $2.45M+51.3% | $1.62M+10.1% | $1.47M-49.1% | $2.89M+61.7% | ||
| $799K— | —— | —— | —— | $0-100% | ||
| $1.8M+800% | $200K— | —— | —— | $0-100% | ||
| $18.16M+1.6% | $17.87M-64.9% | $50.97M+194% | $17.33M+141% | $7.19M-45.7% | ||
| $132M— | —— | —— | $259.5M+273% | $69.5M— | ||
| —— | $62.5M0.0% | $62.5M0.0% | $62.5M0.0% | $62.5M— | ||
| $8.27M— | —— | —— | —— | $10.7M— | ||
| $1.04M-30.9% | $1.5M+331% | $349K-26.4% | $474K+13.9% | $416K0.0% | ||
| —— | $62.5M0.0% | $62.5M0.0% | $62.5M0.0% | $62.5M— | ||
| $234.26M-28.2% | $326.33M-12.1% | $371.23M+145% | $151.64M-27.1% | $207.94M-10.7% | ||
| $234.26M-28.2% | $326.33M-12.1% | $371.23M+145% | $151.64M-27.1% | $207.94M-10.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Idexx Laboratories generate?
- Idexx Laboratories (IDXX) generated $1.2B in operating cash flow over the trailing twelve months.
- What is Idexx Laboratories's free cash flow?
- After $126.6M of capital expenditures, Idexx Laboratories's free cash flow was $1.1B over the trailing twelve months, up 27.8% year over year.
- Where does Idexx Laboratories's cash flow data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
